Delivery Order SPE2DB22D2211-SPE2DB25FSGEA
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $17,260.58 to AmerisourceBergen Drug Corp for OFEV 100 mg capsules (60-count units) on September 22, 2025, with completion targeted for October 14, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $25,890.84 for OFEV 100 mg capsules (60-count units) on September 29, 2025, with an ultimate completion date of October 21, 2025. This firm fixed-price contract utilizes no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of OFEV 150 mg capsules (60-count units) valued at $8,590.58 with a completion date of October 10, 2025. This is a firm fixed-price, non-set-aside contract delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion comprehensive global pharmaceutical support vehicle running through December...
- The Defense Logistics Agency awarded a delivery order valued at $8,590.58 to AmerisourceBergen Drug Corp for OFEV 150 mg capsules (60-count units) on August 29, 2025, with completion targeted for September 22, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $8,630.28 to AmerisourceBergen Drug Corp for OFEV 100 mg capsules (60-count units) on July 23, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of OFEV 100 mg capsules (60-count units) valued at $8,630.28 with a firm fixed-price structure. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. The work will be performed at the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $8,590.58 to AmerisourceBergen Drug Corp for OFEV 150 mg capsules (60-count units) on June 2, 2025, with an ultimate completion date of June 24, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreement with DLA. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $17,260.58 to AmerisourceBergen Drug Corp for the supply of OFEV 100 mg capsules (60-count units). This is a firm fixed price, non-set-aside contract with an ultimate completion date of October 2, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order under its existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product being...
- The Defense Logistics Agency awarded a delivery order valued at $25,771.74 to AmerisourceBergen Drug Corp for OFEV 150 mg capsules (60-count units) on June 18, 2025, with an ultimate completion date of July 11, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vendor agreement running through December 2026 that serves as...
- The Defense Logistics Agency awarded a delivery order valued at $8,590.58 to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of OFEV 150 mg capsules (60-count units). This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 3, 2025, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a non-set-aside procurement executed under AmerisourceBergen's existing Indefinite...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSGEADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $60,134.06 to AmerisourceBergen Drug Corp for OFEV 150 mg capsules (60-count units) on September 29, 2025, with an ultimate completion date of October 21, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor for military and veteran healthcare systems. The company's comprehensive IDC with DLA enables it to supply a wide range of pharmaceutical products and medical commodities to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This delivery order for OFEV (pirfenidone), a specialty medication for idiopathic pulmonary fibrosis, exemplifies the company's role in fulfilling federal medical supply requirements through competitive, open procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $60.1k | 9/29/25 |